Gastrointestinal lesions and Helicobacter pylori in patients with myeloproliferative disorders

Saudi Medical Journal

Volumn 25, Issue 12, 2004, Pages 1913-1916

  Karaoglu, Ali O ^a   Kadikoylu, Gurhan ^a   Yukselen, Vahit ^a   Yasa, Mehmet H ^a   Bolaman, Zahit ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; ANAGRELIDE; CYTARABINE; HYDROXYUREA; STEROID; UREASE;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BLOOD ANALYSIS; CONTROLLED STUDY; DYSPEPSIA; ECHOGRAPHY; FEMALE; GASTRITIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER; PERIODIC MEDICAL EXAMINATION; PHYSICAL EXAMINATION; PREVALENCE; SPLENECTOMY; STATISTICAL ANALYSIS; STOMACH BIOPSY; STOMACH LESION; TURKEY (REPUBLIC); UREA BREATH TEST;

ADULT; AGED; BIOPSY; COMORBIDITY; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGITIS; FEMALE; GASTRIC MUCOSA; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; LEUKEMIA, MYELOID, CHRONIC; MALE; METAPLASIA; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; PEPTIC ULCER; REFERENCE VALUES; STATISTICS; THROMBOCYTOSIS; TURKEY;

EID: 13844296682     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gray AG, Boughton BJ, Burt DS, Struthers GR. Basophils, histamine and gastric acid secretin in chronic myeloproliferative disorders. Br J Haematol 1982; 51: 117-123.
2. Torgano G, Mandelli C, Massaro P, Abbiati C, Ponzetto A, Bertinieri G, et al. Gastroduodenal lesions in polycythaemia vera: frequency and role of Helicobacter pylori. Br J Haematol 2002; 117: 198-202.
3. Schafer AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984; 64: 1-12.
4. Jacobs P, Maze S, Tayob F, Harries-Jones EP. Myelofibrosis, splenomegaly, and portal hypertension. Acta Haematol 1985; 74: 45-48.
5. Michiels JJ, van Genderen PJ, Lindemans J, van Vliet HH. Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia. Leuk Lymphoma 1996; 22 (Suppl 1): 47-56.
6. Wilbur DL, Ochsner HC. The association of polycythaemia vera and peptic ulcer. Ann Intern Med 1935; 8: 1667-1670.
7. Videbaek A. Polycythaemia Vera. Course et Prognosia. Acta Med Scand 1950; 88: 179-187.
8. Gilbert HS, Warner RRP, Wasserman LR. A study of histamine in myeloproliferative disease. Blood 1966; 28: 795-806.
9. Ishii N, Murakami H, Matsushima T, Tamura J, Sawamura M, Morita K, et al. Histamine excess symptoms in basophilic crisis of chronic myelogenous leukemia. Medicine 1995; 26: 235-240.
10. Saeki T, Nakane H, Nakanishi K, Hirono M, Niimoto M, Hattori T, et al. Four gastrectomized cases associated with chronic leukemia. Gan No Rinsho 1984; 30: 403-408.
11. Silverstein MN. Primary or hemorrhagic thrombocythemia. Arch Intern Med 1968; 122: 18-22.
12. Fedeli G, Certo M, Cannizzaro O, Forti G, Perniola R, Manna R, et al. Extramedullary hematopoiesis involving the esophagus in myelofibrosis. Am J Gastroenterol 1990; 85: 1512-1514.
13. Silverstein MN, Wollaeger EE, Baggenstoss AH. Gastrointestinal and abdominal manifestations of agnogenic myeloid metaplasia. Arch Intern Med 1973; 131: 532-537.
14. Suzuki K, Konishi N, Tokura Y, Takigawa M. Telangiectasia macularis eruptiva perstans in polycythemia rubra vera. Eur J Dermatol 2002; 12: 201-203.
15. Westin J, Granerus G, Weinfeld A, Wetterquist H. Histamine metabolism in polycythaemia vera. Scand J Haematol 1975; 15: 45-57.
16. Valimaki M, Vuopio P, Salaspuro M. Plasma histamine and serum pepsinogen I concentrations in chronic myelogenous leukaemia. Acta Med Scand 1985; 217: 89-93.
17. Larson RS, Wolff SN. Chronic myeloid leukemia. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM editors. Wintrobe's Clinical Hematology, 10th ed. Maryland: Williams-Wilkins; 1999. p. 2342-2375.
18. Pearson TC. Evaluation of diagnostic criteria in polycythemia vera. Semin Hematol 2001; 38 (1 Suppl 2): 21-24.
19. Murphy S, Peterson P, Iland H, Rosenthal D, Laszlo J. Essential thrombocythemia: an interim report from the polycythemia vera study group. Semin Hematol 1986; 23: 177-182.
20. Rupoli S, Da Lio L, Sisti S, Campanati G, Salvi A, Brianzoni MF, et al. Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival. Ann Hematol 1994; 68:205-12.
21. Schabowski J. Selected socio-economic features and the prevalence of peptic ulcer among Polish rural population. Ann Agric Environ Med 2002; 9: 79-84.
22. Kurata JH, Nogawa AN, Abbey DE, Petersen F. A prospective study of risk for peptic ulcer disease in Seventh-Day Adventists. Gastroenterology 1992; 102: 902-909.
23. Erkan T, Kutlu T, Cullu F, Goksel S, Tumay TG. Peptic ulcer in pediatric patients: Retrospective analysis of 41 cases. Cerrahpasa J Med 1998; 29: 84-88.
24. Turkdogan MK, Hekim H, Tuncer I, Aksoy H. The epidemiological and endoscopic aspects of peptic ulcer disease in Van region. Eastern Journal of Medicine 1999; 4: 6-9.
25. Peterson WL, Graham DY. Helicobacter pylor. In: Feldman M, Scharschmidt BF, Sleisenger MH, editors. Sleisenger and Fordtran's Gastrointestinal and Liver disease, 6th ed. Philadelphia (PA): WB Saunders; 1998. p. 604-619.